KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Other Accumulated Expenses (2017 - 2018)

Alnylam Pharmaceuticals' Other Accumulated Expenses history spans 5 years, with the latest figure at $23.6 million for Q4 2018.

  • For Q4 2018, Other Accumulated Expenses rose 117.66% year-over-year to $23.6 million; the TTM value through Dec 2018 reached $23.6 million, up 117.66%, while the annual FY2018 figure was $23.6 million, 117.66% up from the prior year.
  • Other Accumulated Expenses reached $23.6 million in Q4 2018 per ALNY's latest filing, up from $10.9 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $25.4 million in Q1 2014 to a low of $3.8 million in Q4 2014.
  • Average Other Accumulated Expenses over 4 years is $13.7 million, with a median of $10.9 million recorded in 2017.
  • Peak YoY movement for Other Accumulated Expenses: increased 16.6% in 2014, then surged 117.66% in 2018.
  • A 4-year view of Other Accumulated Expenses shows it stood at $3.8 million in 2014, then soared by 30.38% to $5.0 million in 2015, then soared by 118.69% to $10.9 million in 2017, then soared by 117.66% to $23.6 million in 2018.
  • Per Business Quant, the three most recent readings for ALNY's Other Accumulated Expenses are $23.6 million (Q4 2018), $10.9 million (Q4 2017), and $5.0 million (Q4 2015).